ID   NPHN_RAT                Reviewed;        1252 AA.
AC   Q9R044; Q9JIX2; Q9QXX7;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 2.
DT   02-OCT-2024, entry version 175.
DE   RecName: Full=Nephrin;
DE   AltName: Full=Renal glomerulus-specific cell adhesion receptor;
DE   Flags: Precursor;
GN   Name=Nphs1; Synonyms=Nphn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=10820162; DOI=10.1681/asn.v116991;
RA   Putaala H., Sainio K., Sariola H., Tryggvason K.;
RT   "Primary structure of mouse and rat nephrin cDNA and structure and
RT   expression of the mouse gene.";
RL   J. Am. Soc. Nephrol. 11:991-1001(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RC   STRAIN=Wistar; TISSUE=Renal glomerulus;
RX   PubMed=10792613; DOI=10.1046/j.1523-1755.2000.00044.x;
RA   Kawachi H., Koike H., Kurihara H., Yaoita E., Orikasa M., Shia M.A.,
RA   Sakai T., Yamamoto T., Salant D.J., Shimizu F.;
RT   "Cloning of rat nephrin: expression in developing glomeruli and in
RT   proteinuric states.";
RL   Kidney Int. 57:1949-1961(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-1252 (ISOFORMS 1; 2 AND 3), FUNCTION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Renal glomerulus;
RX   PubMed=10487848; DOI=10.1016/s0002-9440(10)65190-5;
RA   Ahola H., Wang S.-X., Luimula P., Solin M.-L., Holzman L.B., Holthoefer H.;
RT   "Cloning and expression of the rat nephrin homolog.";
RL   Am. J. Pathol. 155:907-913(1999).
RN   [4]
RP   INDUCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=11012881; DOI=10.1046/j.1523-1755.2000.00308.x;
RA   Luimula P., Ahola H., Wang S.X., Solin M.L., Aaltonen P., Tikkanen I.,
RA   Kerjaschki D., Holthofer H.;
RT   "Nephrin in experimental glomerular disease.";
RL   Kidney Int. 58:1461-1468(2000).
RN   [5]
RP   FUNCTION.
RX   PubMed=11880318; DOI=10.1152/ajprenal.00290.2001;
RA   Yuan H., Takeuchi E., Salant D.J.;
RT   "Podocyte slit-diaphragm protein nephrin is linked to the actin
RT   cytoskeleton.";
RL   Am. J. Physiol. 282:F585-F591(2002).
RN   [6]
RP   INTERACTION WITH MAGI1.
RX   PubMed=16155592; DOI=10.1038/labinvest.3700347;
RA   Hirabayashi S., Mori H., Kansaku A., Kurihara H., Sakai T., Shimizu F.,
RA   Kawachi H., Hata Y.;
RT   "MAGI-1 is a component of the glomerular slit diaphragm that is tightly
RT   associated with nephrin.";
RL   Lab. Invest. 85:1528-1543(2005).
RN   [7]
RP   INTERACTION WITH ACTN4; CASK; IQGAP1; MAGI2; SPTAN1 AND SPTBN1.
RC   STRAIN=Sprague-Dawley; TISSUE=Renal glomerulus;
RX   PubMed=15994232; DOI=10.1073/pnas.0504166102;
RA   Lehtonen S., Ryan J.J., Kudlicka K., Iino N., Zhou H., Farquhar M.G.;
RT   "Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and
RT   alpha-actinin are components of the nephrin multiprotein complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9814-9819(2005).
RN   [8]
RP   INTERACTION WITH DDN.
RX   PubMed=17537921; DOI=10.1073/pnas.0700917104;
RA   Asanuma K., Campbell K.N., Kim K., Faul C., Mundel P.;
RT   "Nuclear relocation of the nephrin and CD2AP-binding protein dendrin
RT   promotes apoptosis of podocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:10134-10139(2007).
RN   [9]
RP   PHOSPHORYLATION AT TYR-1204 BY FYN.
RX   PubMed=19179337; DOI=10.1074/jbc.m806851200;
RA   Harita Y., Kurihara H., Kosako H., Tezuka T., Sekine T., Igarashi T.,
RA   Ohsawa I., Ohta S., Hattori S.;
RT   "Phosphorylation of nephrin triggers Ca2+ signaling by recruitment and
RT   activation of phospholipase C-{gamma}1.";
RL   J. Biol. Chem. 284:8951-8962(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1112; THR-1115 AND SER-1119,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Seems to play a role in the development or function of the
CC       kidney glomerular filtration barrier. Regulates glomerular vascular
CC       permeability. May anchor the podocyte slit diaphragm to the actin
CC       cytoskeleton. Plays a role in skeletal muscle formation through
CC       regulation of myoblast fusion. {ECO:0000269|PubMed:10487848,
CC       ECO:0000269|PubMed:11880318}.
CC   -!- SUBUNIT: Interacts with NPHS2 and with CD2AP (via C-terminal domain).
CC       Self-associates (via the Ig-like domains). Also interacts (via the Ig-
CC       like domains) with KIRREL1/NEPH1 and KIRREL2; the interaction with
CC       KIRREL1 is dependent on KIRREL1 glycosylation. Interacts with KIRREL3
CC       (By similarity). Interacts with MAGI1 (via PDZ 2 and 3 domains) forming
CC       a tripartite complex with IGSF5/JAM4. Interacts with DDN; the
CC       interaction is direct. Forms a complex with ACTN4, CASK, IQGAP1, MAGI2,
CC       SPTAN1 and SPTBN1. Interacts with phosphatidylinositol 3-kinase
CC       regulatory subunit PIK3R1; the interaction is reduced by high glucose
CC       levels (By similarity). {ECO:0000250|UniProtKB:O60500,
CC       ECO:0000250|UniProtKB:Q9QZS7, ECO:0000269|PubMed:15994232,
CC       ECO:0000269|PubMed:16155592, ECO:0000269|PubMed:17537921}.
CC   -!- INTERACTION:
CC       Q9R044; P97710: Sirpa; NbExp=2; IntAct=EBI-7945021, EBI-7945080;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Located at podocyte slit diaphragm
CC       between podocyte foot processes. {ECO:0000269|PubMed:10792613}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=1;
CC         IsoId=Q9R044-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=Q9R044-2; Sequence=VSP_002599;
CC       Name=3; Synonyms=Beta;
CC         IsoId=Q9R044-3; Sequence=VSP_002600;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in the podocytes of kidney
CC       glomeruli (at protein level) and at lower levels in the spleen.
CC       {ECO:0000269|PubMed:10487848, ECO:0000269|PubMed:11012881}.
CC   -!- INDUCTION: Following injection with puromycin which induces nephrosis,
CC       down-regulated by 40% 3 days post-injection and by 80% at day 10. Also
CC       down-regulated by HgCl2 with rapid decrease at day 3.
CC       {ECO:0000269|PubMed:11012881}.
CC   -!- PTM: Phosphorylated at Tyr-1204 by FYN, leading to the recruitment and
CC       activation of phospholipase C-gamma-1/PLCG1 (PubMed:19179337). Tyrosine
CC       phosphorylation is reduced by high glucose levels (By similarity).
CC       Dephosphorylated by tensin TNS2 which leads to reduced binding of NPHN1
CC       to PIK3R1 (By similarity). {ECO:0000250|UniProtKB:O60500,
CC       ECO:0000269|PubMed:19179337}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF172255; AAF91086.1; -; mRNA.
DR   EMBL; AF161715; AAF14884.1; -; mRNA.
DR   EMBL; AF125521; AAF12734.1; -; mRNA.
DR   RefSeq; NP_072150.1; NM_022628.1.
DR   AlphaFoldDB; Q9R044; -.
DR   BioGRID; 249144; 8.
DR   CORUM; Q9R044; -.
DR   IntAct; Q9R044; 1.
DR   MINT; Q9R044; -.
DR   STRING; 10116.ENSRNOP00000049922; -.
DR   GlyCosmos; Q9R044; 6 sites, No reported glycans.
DR   GlyGen; Q9R044; 6 sites.
DR   iPTMnet; Q9R044; -.
DR   PhosphoSitePlus; Q9R044; -.
DR   PaxDb; 10116-ENSRNOP00000049922; -.
DR   GeneID; 64563; -.
DR   KEGG; rno:64563; -.
DR   UCSC; RGD:620460; rat. [Q9R044-1]
DR   AGR; RGD:620460; -.
DR   CTD; 4868; -.
DR   RGD; 620460; Nphs1.
DR   eggNOG; KOG3515; Eukaryota.
DR   InParanoid; Q9R044; -.
DR   OrthoDB; 2875972at2759; -.
DR   PhylomeDB; Q9R044; -.
DR   Reactome; R-RNO-373753; Nephrin family interactions.
DR   PRO; PR:Q9R044; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005604; C:basement membrane; IDA:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0042995; C:cell projection; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; IBA:GO_Central.
DR   GO; GO:0005925; C:focal adhesion; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0036057; C:slit diaphragm; IDA:UniProtKB.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0030507; F:spectrin binding; IPI:RGD.
DR   GO; GO:0007155; P:cell adhesion; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0003094; P:glomerular filtration; IC:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0007520; P:myoblast fusion; ISO:RGD.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0036060; P:slit diaphragm assembly; ISS:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   CDD; cd00096; Ig; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 10.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR051275; Cell_adhesion_signaling.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR11640:SF162; LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; 1.
DR   PANTHER; PTHR11640; NEPHRIN; 1.
DR   Pfam; PF08205; C2-set_2; 4.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13927; Ig_3; 1.
DR   SMART; SM00060; FN3; 1.
DR   SMART; SM00409; IG; 8.
DR   SMART; SM00408; IGc2; 7.
DR   SUPFAM; SSF49265; Fibronectin type III; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 9.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS50835; IG_LIKE; 7.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Developmental protein;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane; Myogenesis;
KW   Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..35
FT                   /evidence="ECO:0000255"
FT   CHAIN           36..1252
FT                   /note="Nephrin"
FT                   /id="PRO_0000015054"
FT   TOPO_DOM        36..1078
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1079..1099
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1100..1252
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          39..144
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          149..247
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          256..347
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          354..448
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          454..554
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          558..649
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          754..846
FT                   /note="Ig-like C2-type 7"
FT   DOMAIN          852..953
FT                   /note="Ig-like C2-type 8"
FT   DOMAIN          957..1052
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          1043..1067
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1113..1144
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1113..1135
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         446
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60500"
FT   MOD_RES         1112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1115
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1204
FT                   /note="Phosphotyrosine; by FYN"
FT                   /evidence="ECO:0000269|PubMed:19179337"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        370
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        561
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        578
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        722
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        67..125
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        174..231
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        279..331
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        375..431
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        479..542
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        581..637
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        775..830
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        877..934
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1070..1155
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10487848"
FT                   /id="VSP_002600"
FT   VAR_SEQ         1070..1082
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10487848"
FT                   /id="VSP_002599"
FT   CONFLICT        19
FT                   /note="M -> T (in Ref. 2; AAF14884)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        46
FT                   /note="R -> Q (in Ref. 2; AAF14884)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1229
FT                   /note="D -> N (in Ref. 3; AAF12734)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1252 AA;  136281 MW;  6A3550AB907883EC CRC64;
     MGAKRVTVRG ARTSPIHRMS SLTPLLLMGM LTSGLAESPV PTSAPRGFWA LSENLTAVEG
     TTVKLWCGVR APGSVVQWAK DGLLLGPNPK MPGFPRYSLE GDRAKGEFHL LIEACDLSDD
     AEYECQVGRS ELGPELVSPK VILSILVSPK VLLLTPEAGS TVTWVAGQEY VVTCVSGDAK
     PAPDITFIQS GRTILDVSSN VNEGSEEKLC ITEAEARVIP QSSDNGQLLV CEGSNPALDT
     PIKASFTMNI LFPPGPPVID WPGLNEGHVR AGENLELPCT ARGGNPPATL QWLKNGKPVS
     TAWGTEHAQA VAHSVLVMTV RPEDHGARLS CQSYNSVSAG TQERSITLQV TFPPSAITIL
     GSVSQSENKN VTLCCLTKSS RPRVLLRWWL GGRQLLPTDE TVMDGLHGGH ISMSNLTFLV
     RREDNGLPLT CEAFSDAFSK ETFKKSLTLN VKYPAQKLWI EGPPEGQYIR TGTRVRLVCL
     AIGGNPDPSL IWFKDSRPVS EPRQPQEPRR VQLGSVEKSG STFSRELVLI IGPPDNRAKF
     SCKAGQLSAS TQLVVQFPPT NLTILANSSA LRPGDALNLT CVSISSNPPV NLSWDKEGER
     LEDVAAKPQS APFKGSAASR SVFLRVSSRD HGQRVTCRAH SEALRETVSS FYRFNVLYPP
     EFLGEQVRAV TVVEQGQVLL PVSVSANPAP EAFNWTFRGY RLSPAGGPRH RILSGGALQL
     WNVTRADDGF YQLHCQNSEG TAEALLKLDV HYAPTIRALR DPTEVNVGGS VDIVCTVDAN
     PILPEMFSWE RLGEEEEDLN LDDMEKVSKG STGRLRIRQA KLSQAGAYQC IVDNGVAPAA
     RGLVRLVVRF APQVDQPTPL TKVAAAGDST SSATLHCRAR GVPNIDFTWT KNGVPLDLQD
     PRYTEHRYHQ GVVHSSLLTI ANVSAAQDYA LFKCTATNAL GSDHTNIQLV SISRPDPPLG
     LKVVSISPHS VGLEWKPGFD GGLPQRFQIR YEALETPGFL HVDVLPTQAT TFTLTGLKPS
     TRYRIWLLAS NALGDSGLTD KGIQVSVTTP GPDQAPEDTD HQLPTELPPG PPRLPLLPVL
     FAVGGLLLLS NASCVGGLLW RRRLRRLAEE ISEKTEAGSE DRIRNEYEES QWTGDRDTRS
     STVSTAEVDP NYYSMRDFSP QLPPTLEEVL YHQGAEGEDM AFPGHLHDEV ERAYGPPGAW
     GPLYDEVRMD PYDLRWPEVQ CEDPRGIYDQ VAADMDAVEA SSLPFELRGH LV
//
